{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:49:12Z","timestamp":1790225352095,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Taighde \u00c9ireann \u2013 Research Ireland","doi-asserted-by":"publisher","award":["21\/PATH-S\/9454"],"award-info":[{"award-number":["21\/PATH-S\/9454"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Taighde \u00c9ireann \u2013 Research Ireland","doi-asserted-by":"publisher","award":["19\/FFP\/6896"],"award-info":[{"award-number":["19\/FFP\/6896"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPG\/2022\/1051"],"award-info":[{"award-number":["GOIPG\/2022\/1051"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/04326\/2020"],"award-info":[{"award-number":["UIDB\/04326\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["LA\/P\/0101\/2020"],"award-info":[{"award-number":["LA\/P\/0101\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejps.2026.107463","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T08:04:28Z","timestamp":1770797068000},"page":"107463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhalable dry powder formulations of the commercialised form of Deoxyribonuclease I - a dried alternative for the treatment of cystic fibrosis"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5415-3801","authenticated-orcid":false,"given":"Aoife B.","family":"Cotter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarinda","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasser","family":"Alhajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Pinto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Grenha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8632-2320","authenticated-orcid":false,"given":"Luis","family":"Padrela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejps.2026.107463_bib0001","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jps.20842","article-title":"The challenge of drying method selection for protein pharmaceuticals: product quality implications","volume":"96","author":"Abdul-Fattah","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107463_bib0002","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1023\/A:1007568511399","article-title":"Surface composition of spray-dried particles of bovine serum albumin\/trehalose\/surfactant","volume":"17","author":"Adler","year":"2000","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0003","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0014-5793(83)80350-0","article-title":"CD study of the actin DNase I complex","volume":"151","author":"Ajtai","year":"1983","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.ejps.2026.107463_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239658","article-title":"Colistin dry powder inhalation with the Twincer\u2122: An effective and more patient friendly alternative to nebulization","volume":"15","author":"Akkerman-Nijland","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.ejps.2026.107463_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123151","article-title":"Quality by design \u2013 Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation","volume":"642","author":"Alhajj","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejps.2026.107463_bib0006","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/pharmaceutics14040800","article-title":"Particle Engineering by Nano Spray Drying: Optimization of Process Parameters with Hydroethanolic versus Aqueous Solutions","volume":"14","author":"Almansour","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejps.2026.107463_bib0007","unstructured":"Arna Pharma. (2024). Bronchitol\u00ae (mannitol) inhalation powder: Full prescribing information. https:\/\/bronchitol.com\/wp-content\/uploads\/2025\/05\/2024-06-Bronchitol-Full-Prescribing-Information-PIL-US_summary_clean.pdf."},{"key":"10.1016\/j.ejps.2026.107463_bib0010","series-title":"Food Powders: Physical Properties, Processing, and Functionality","first-page":"55","article-title":"Bulk properties","author":"Barbosa-C\u00e1novas","year":"2005"},{"issue":"7","key":"10.1016\/j.ejps.2026.107463_bib0008","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/pharmaceutics12070625","article-title":"Unraveling Particle Formation: From Single Droplet Drying to Spray Drying and Electrospraying","volume":"12","author":"Boel","year":"2020","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/powders3020015","article-title":"A Comprehensive Review of the Rheological Properties of Powders in Pharmaceuticals","volume":"3","author":"Brubaker","year":"2024","journal-title":"Powders"},{"key":"10.1016\/j.ejps.2026.107463_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.lwt.2021.112495","article-title":"The impact of spray drying conditions on the physicochemical and emulsification properties of pea protein isolate","volume":"153","author":"Burger","year":"2022","journal-title":"LWT"},{"key":"10.1016\/j.ejps.2026.107463_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1023\/A:1012035113276","article-title":"Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery","volume":"14","author":"Chan","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107463_bib0013","series-title":"Interface Science and Technology","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/B978-0-12-818805-7.00007-2","article-title":"Chapter 10 - Membrane adsorption","volume":"33","author":"Changmai","year":"2021"},{"key":"10.1016\/j.ejps.2026.107463_bib0014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpb.2008.05.026","article-title":"Surface composition and contact angle relationships for differently prepared solid dispersions","volume":"70","author":"Dahlberg","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107463_bib0016","article-title":"Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis","volume":"58","author":"de Castro","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.ejps.2026.107463_bib0017","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1680\/si.13.00010","article-title":"Guidelines to measurements of reproducible contact angles using a sessile-drop technique","volume":"1","author":"Drelich","year":"2013","journal-title":"Surf. Innov."},{"issue":"9","key":"10.1016\/j.ejps.2026.107463_bib0018","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/jps.20418","article-title":"Particle Size and Density in Spray Drying\u2014Effects of Carbohydrate Properties","volume":"94","author":"Elversson","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107463_bib0019","series-title":"Committee for Orphan Medicinal Products (COMP)","year":"2024"},{"issue":"2\u20133","key":"10.1016\/j.ejps.2026.107463_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0927-7757(94)02914-8","article-title":"The surface composition of spray-dried protein\u2014lactose powders","volume":"90","author":"F\u00e4ldt","year":"1994","journal-title":"Colloids Surf. A: Physicochem. Eng. Asp."},{"issue":"null","key":"10.1016\/j.ejps.2026.107463_bib0021","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2147\/PPA.S102234","article-title":"Treatment satisfaction in cystic fibrosis: early patient experience with tobramycin inhalation powder","volume":"10","author":"Greenberg","year":"2016","journal-title":"Patient. Prefer. Adherence"},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0022","article-title":"PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long-Acting Version of the Mucolytic for Patients with Cystic Fibrosis","volume":"4","author":"Guichard","year":"2021","journal-title":"Adv. Ther. (Weinh)"},{"issue":"3","key":"10.1016\/j.ejps.2026.107463_bib0023","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"issue":"6","key":"10.1016\/j.ejps.2026.107463_bib0024","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcf.2014.04.004","article-title":"Inhaled versus nebulised tobramycin: A real world comparison in adult cystic fibrosis (CF)","volume":"13","author":"Harrison","year":"2014","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.ejps.2026.107463_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.powtec.2013.05.004","article-title":"The morphology and various densities of spray dried mannitol","volume":"246","author":"Littringer","year":"2013","journal-title":"Powder. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0026","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1757177419855603","article-title":"Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis","volume":"21","author":"MacFarlane","year":"2020","journal-title":"J. Infect. Prev."},{"key":"10.1016\/j.ejps.2026.107463_bib0027","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejpb.2019.09.014","article-title":"The use of hydrophobic amino acids in protecting spray dried trehalose formulations against moisture-induced changes","volume":"144","author":"Mah","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2026.107463_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1936","article-title":"The in vivo expression of actin\/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus","volume":"8","author":"Manderson","year":"2006","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejps.2026.107463_bib0029","series-title":"Ions in Solution and Their Solvation","author":"Marcus","year":"2015"},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jcf.2015.09.002","article-title":"Causes of death in French cystic fibrosis patients: The need for improvement in transplantation referral strategies!","volume":"15","author":"Martin","year":"2016","journal-title":"J. Cyst. Fibros."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2026.107463_bib0031","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: Advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.ejps.2026.107463_bib0033","first-page":"175","volume":"(Vol. 2199,","author":"Micsonai","year":"2021"},{"issue":"9","key":"10.1016\/j.ejps.2026.107463_bib0034","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/pro.3474","article-title":"CDtoolX, a downloadable software package for processing and analyses of circular dichroism spectroscopic data","volume":"27","author":"Miles","year":"2018","journal-title":"Protein Sci."},{"issue":"6","key":"10.1016\/j.ejps.2026.107463_bib0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3111\/13696998.2013.787427","article-title":"Adherence to dornase alfa treatment among commercially insured patients with cystic fibrosis","volume":"16","author":"Nasr","year":"2013","journal-title":"J. Med. Econ."},{"issue":"24","key":"10.1016\/j.ejps.2026.107463_bib0036","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1016\/j.ces.2009.08.038","article-title":"Drop penetration time in heterogeneous powder beds","volume":"64","author":"Nguyen","year":"2009","journal-title":"Chem. Eng. Sci."},{"issue":"9","key":"10.1016\/j.ejps.2026.107463_bib0037","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4187\/respcare.09582","article-title":"Nebulizer Cleaning Practices and Adherence to Nebulized Therapies in People With Cystic Fibrosis When Traveling","volume":"67","author":"O\u2019Doherty","year":"2022","journal-title":"Respir. Care"},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lwt.2014.02.016","article-title":"Effects of spray drying conditions and the addition of surfactants on the foaming properties of a whey protein concentrate","volume":"58","author":"Osorio","year":"2014","journal-title":"LWT - Food Sci. Technol."},{"issue":"3\u20134","key":"10.1016\/j.ejps.2026.107463_bib0039","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0009-2614(86)80078-1","article-title":"Hydration shell structure of the calcium ion","volume":"126","author":"Palinkas","year":"1986","journal-title":"Chem. Phys. Lett."},{"issue":"8","key":"10.1016\/j.ejps.2026.107463_bib0040","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40261-017-0537-9","article-title":"Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis","volume":"37","author":"Panguluri","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ejps.2026.107463_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106775","article-title":"Development of a dry powder insufflation device with application in in vitro cell-based assays in the context of respiratory delivery","volume":"197","author":"Pontes","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0042","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0025-5408(72)90273-5","article-title":"Effects of particle shape on angles of repose and bulk densities of a granular solid","volume":"7","author":"Riley","year":"1972","journal-title":"Mater. Res. Bull."},{"issue":"12","key":"10.1016\/j.ejps.2026.107463_bib0043","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1111\/j.1750-3841.2012.02990.x","article-title":"True Density and Apparent Density During the Drying Process for Vegetables and Fruits: A Review","volume":"77","author":"Rodr\u00edguez-Ram\u00edrez","year":"2012","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ejps.2026.107463_bib0032","series-title":"Directory of Therapeutic Enzymes","article-title":"Deoxyribonuclease I","author":"Sanders","year":"2005"},{"issue":"6","key":"10.1016\/j.ejps.2026.107463_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/genes11060589","article-title":"The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery","volume":"11","author":"Scotet","year":"2020","journal-title":"Genes. (Basel)"},{"issue":"23","key":"10.1016\/j.ejps.2026.107463_bib0045","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.87.23.9188","article-title":"Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum","volume":"87","author":"Shak","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0046","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijpharm.2016.01.066","article-title":"Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate","volume":"501","author":"Simon","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2026.107463_bib0047","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/abio.1994.1502","article-title":"Colorimetric determination of DNase I activity with a DNA-methyl green substrate","volume":"222","author":"Sinicropi","year":"1994","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2026.107463_bib0048","series-title":"Pharmaceutical Dosage Forms-Tablets","first-page":"243","article-title":"Spray drying: theory and pharmaceutical applications","author":"Snyder","year":"2008"},{"key":"10.1016\/j.ejps.2026.107463_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104629","article-title":"DJ-1 can form \u03b2-sheet structured aggregates that co-localize with pathological amyloid deposits","volume":"134","author":"Solti","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2026.107463_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-5173(01)00945-0","article-title":"The effect of process variables on the degradation and physical properties of spray dried insulin intended for inhalation","volume":"233","author":"St\u00e5hl","year":"2002","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejps.2026.107463_bib0051","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.powtec.2004.08.003","article-title":"Comparison of different flowability tests for powders for inhalation","volume":"146","author":"Thalberg","year":"2004","journal-title":"Powder. Technol."},{"key":"10.1016\/j.ejps.2026.107463_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111646","article-title":"Deltamethrin modulates the native structure of Hen Egg White Lysozyme and induces its aggregation at physiological pH","volume":"201","author":"Varma","year":"2021","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14787210.2016.1118344","article-title":"Tobramycin inhalation powder (TOBI Podhaler\u00ae) for the treatment of lung infection in patients with cystic fibrosis","volume":"14","author":"Vazquez-Espinosa","year":"2016","journal-title":"Expert. Rev. Anti. Infect. Ther."},{"issue":"7","key":"10.1016\/j.ejps.2026.107463_bib0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jaerosci.2007.04.005","article-title":"Particle formation in spray drying","volume":"38","author":"Vehring","year":"2007","journal-title":"J. Aerosol. Sci."},{"key":"10.1016\/j.ejps.2026.107463_bib0054","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.ejps.2026.107463_bib0056","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0039-9140(02)00058-9","article-title":"About pycnometric density measurements","volume":"57","author":"Viana","year":"2002","journal-title":"Talanta"},{"key":"10.1016\/j.ejps.2026.107463_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.powtec.2013.06.038","article-title":"Fundamental analysis of particle formation in spray drying","volume":"247","author":"Vicente","year":"2013","journal-title":"Powder. Technol."},{"issue":"40_suppl","key":"10.1016\/j.ejps.2026.107463_bib0058","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/014107680109440s06","article-title":"Mucolytic therapy in cystic fibrosis","volume":"94","author":"Wallis","year":"2001","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.ejps.2026.107463_bib0059","author":"Wark"},{"key":"10.1016\/j.ejps.2026.107463_bib0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.powtec.2021.04.090","article-title":"Solvent evaporation kinetics in spray drying and how to consider heat loss","volume":"388","author":"Weiler","year":"2021","journal-title":"Powder. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107463_bib0061","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11095-019-2738-9","article-title":"Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying","volume":"37","author":"Wilson","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107463_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115144","article-title":"Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano\u2013bio interactions","volume":"203","author":"Zhang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2026.107463_bib0063","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2018.10.026","article-title":"Spray drying of pharmaceuticals and biopharmaceuticals: Critical parameters and experimental process optimization approaches","volume":"127","author":"Ziaee","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107463_bib0064","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.powtec.2020.02.057","article-title":"A rational approach towards spray drying of biopharmaceuticals: The case of lysozyme","volume":"366","author":"Ziaee","year":"2020","journal-title":"Powder. Technol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726000370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:50:26Z","timestamp":1776185426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726000370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":64,"alternative-id":["S0928098726000370"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107463","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable dry powder formulations of the commercialised form of Deoxyribonuclease I - a dried alternative for the treatment of cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107463"}}